Elekta AB (publ) (OTCMKTS:EKTAY) Raised to Hold at Sanford C. Bernstein

Sanford C. Bernstein upgraded shares of Elekta AB (publ) (OTCMKTS:EKTAY) from a strong sell rating to a hold rating in a research note published on Wednesday morning,Zacks.com reports.

Elekta AB (publ) Price Performance

Elekta AB (publ) stock opened at $5.87 on Wednesday. The stock has a market cap of $2.25 billion, a P/E ratio of 23.48 and a beta of 1.22. The company has a fifty day simple moving average of $5.63 and a 200-day simple moving average of $6.11. Elekta AB has a 12-month low of $5.25 and a 12-month high of $8.24. The company has a current ratio of 1.05, a quick ratio of 0.81 and a debt-to-equity ratio of 0.60.

Elekta AB (publ) (OTCMKTS:EKTAY) last released its quarterly earnings data on Wednesday, November 27th. The company reported $0.06 earnings per share (EPS) for the quarter. Elekta AB (publ) had a net margin of 5.65% and a return on equity of 11.07%. Equities analysts expect that Elekta AB will post 0.36 EPS for the current fiscal year.

Elekta AB (publ) Company Profile

Elekta AB (publ), a medical technology company, provides clinical solutions for treating cancer and brain disorders worldwide. The company offers Versa HD, a brain metastases solution; Elekta Unity for real-time MR visualization; Elekta Harmony, a linear accelerator; Elekta Infinity for treating a range of patients with simple-to-complex radiotherapy needs; Elekta Synergy, a digital accelerator for image guided radiation therapy; treatment and workflow management solutions; radiation and medical oncology; and other patient services.